Ansell Limited (PD1A) - Total Liabilities
Based on the latest financial reports, Ansell Limited (PD1A) has total liabilities worth €1.34 Billion EUR (≈ $1.57 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Ansell Limited - Total Liabilities Trend (2004–2025)
This chart illustrates how Ansell Limited's total liabilities have evolved over time, based on quarterly financial data. See PD1A net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Ansell Limited Competitors by Total Liabilities
The table below lists competitors of Ansell Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Almirall S.A.
MC:ALM
|
Spain | €882.40 Million |
|
Atlanta Braves Holdings, Inc. Series C Common Stock
NASDAQ:BATRK
|
USA | $7.49 Billion |
|
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
|
USA | $232.18 Million |
|
Shandong Humon Smelting Co Ltd
SHE:002237
|
China | CN¥25.69 Billion |
|
CES Energy Solutions Corp
TO:CEU
|
Canada | CA$850.54 Million |
|
CLARIANT ADR 1/SF 4
F:CLRS
|
Germany | €3.69 Billion |
|
Momentum Metropolitan Holdings Ltd
JSE:MTM
|
South Africa | ZAC848.83 Billion |
|
TP ICAP GROUP PLC LS -25
F:8D7
|
Germany | €6.14 Billion |
Liability Composition Analysis (2004–2025)
This chart breaks down Ansell Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Ansell Limited market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.68 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ansell Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ansell Limited (2004–2025)
The table below shows the annual total liabilities of Ansell Limited from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | €1.34 Billion ≈ $1.57 Billion |
+0.55% |
| 2024-06-30 | €1.33 Billion ≈ $1.56 Billion |
+45.59% |
| 2023-06-30 | €915.20 Million ≈ $1.07 Billion |
-3.62% |
| 2022-06-30 | €949.60 Million ≈ $1.11 Billion |
-19.05% |
| 2021-06-30 | €1.17 Billion ≈ $1.37 Billion |
-22.97% |
| 2020-06-30 | €1.52 Billion ≈ $1.78 Billion |
+10.51% |
| 2019-06-30 | €1.38 Billion ≈ $1.61 Billion |
+4.76% |
| 2018-06-30 | €1.32 Billion ≈ $1.54 Billion |
-17.18% |
| 2017-06-30 | €1.59 Billion ≈ $1.86 Billion |
+2.22% |
| 2016-06-30 | €1.55 Billion ≈ $1.82 Billion |
+28.44% |
| 2015-06-30 | €1.21 Billion ≈ $1.41 Billion |
-0.79% |
| 2014-06-30 | €1.22 Billion ≈ $1.43 Billion |
+145.33% |
| 2006-06-30 | €497.05 Million ≈ $581.11 Million |
+7.73% |
| 2005-06-30 | €461.39 Million ≈ $539.41 Million |
-4.21% |
| 2004-06-30 | €481.69 Million ≈ $563.15 Million |
-- |
About Ansell Limited
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, single-use and examination gloves,… Read more